Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder

  • Amann, Benedikt L.|||0000-0002-4407-1519
  • Canales-Rodriguez, Erick Jorge|||0000-0001-6421-2633
  • Madre Rull, Mercè|||0000-0002-4660-3216
  • Radua, Joaquim|||0000-0003-1240-5438
  • Monte, G.
  • Alonso-Lana, Silvia|||0000-0002-3063-6929
  • Landin-Romero, Ramon|||0000-0003-0485-8090
  • Moreno Alcázar, Ana|||0000-0002-3392-5590
  • Bonnin, Caterina del Mar|||0000-0002-1197-1596
  • Sarró, Salvador|||0000-0003-1835-2189
  • Ortiz-Gil, Jordi|||0000-0001-7910-8062
  • Gomar, J. J.
  • Moro, N.
  • Fernandez-Corcuera, P.
  • Goikolea Alberdi, Jose Manuel|||0000-0003-0676-0791
  • Blanch, J.
  • Salvador, R.
  • Vieta, Eduard|||0000-0002-0548-0053
  • McKenna, P. J.
  • Pomarol-Clotet, E.
Brain structural changes in schizoaffective disorder, and how far they resemble those seen in schizophrenia and bipolar disorder, have only been studied to a limited extent. Forty-five patients meeting - and criteria for schizoaffective disorder, groups of patients with 45 matched schizophrenia and bipolar disorder, and 45 matched healthy controls were examined using voxel-based morphometry (). Analyses comparing each patient group with the healthy control subjects found that the patients with schizoaffective disorder and the patients with schizophrenia showed widespread and overlapping areas of significant volume reduction, but the patients with bipolar disorder did not. A subsequent analysis compared the combined group of patients with the controls followed by extraction of clusters. In regions where the patients differed significantly from the controls, no significant differences in mean volume between patients with schizoaffective disorder and patients with schizophrenia in any of five regions of volume reduction were found, but mean volumes in the patients with bipolar disorder were significantly smaller in three of five. The findings provide evidence that, in terms of structural gray matter brain abnormality, schizoaffective disorder resembles schizophrenia more than bipolar disorder.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Eye movement desensitization and reprocessing therapy versus supportive therapy in affective relapse prevention in bipolar patients with a history of trauma, study protocol for a randomized controlled trial

  • Moreno Alcázar, Ana|||0000-0002-3392-5590
  • Radua, Joaquim|||0000-0003-1240-5438
  • Landin-Romero, Ramon|||0000-0003-0485-8090
  • Blanco Presas, Laura|||0000-0001-6272-4416
  • Madre Rull, Mercè|||0000-0002-4660-3216
  • Reinares, María|||0000-0001-8859-4453
  • Comes, Mercè
  • Jiménez, Esther
  • Crespo, José Manuel
  • Vieta, Eduard|||0000-0002-0548-0053
  • Pérez Solà, Víctor|||0000-0002-5825-2337
  • Novo, Patricia
  • Doñate, Marta
  • Cortizo, Romina|||0000-0001-7544-8537
  • Valiente Gomez, Alicia|||0000-0003-0220-2397
  • Lupo, Walter
  • McKenna, Peter J.
  • Pomarol-Clotet, Edith|||0000-0002-8159-8563
  • Amann, Benedikt L.|||0000-0002-4407-1519
Up to 60% of patients with bipolar disorder (BD) have a history of traumatic events, which is associated with greater episode severity, higher risk of comorbidity and higher relapse rates. Trauma-focused treatment strategies for BD are thus necessary but studies are currently scarce. The aim of this study is to examine whether Eye Movement Desensitization and Reprocessing (EMDR) therapy focusing on adherence, insight, de-idealisation of manic symptoms, prodromal symptoms and mood stabilization can reduce episode severity and relapse rates and increase cognitive performance and functioning in patients with BD. This is a single-blind, randomized controlled, multicentre trial in which 82 patients with BD and a history of traumatic events will be recruited and randomly allocated to one of two treatment arms: EMDR therapy or supportive therapy. Patients in both groups will receive 20 psychotherapeutic sessions, 60 min each, during 6 months. The primary outcome is a reduction of affective episodes after 12 and 24 months in favour of the EMDR group. As secondary outcome we postulate a greater reduction in affective symptoms in the EMDR group (as measured by the Bipolar Depression Rating Scale, the Young Mania Rating Scale and the Clinical Global Impression Scale modified for BD), and a better performance in cognitive state, social cognition and functioning (as measured by the Screen for Cognitive Impairment in Psychiatry, The Mayer-Salovey-Caruso Emotional Intelligence Test and the Functioning Assessment Short Test, respectively). Traumatic events will be evaluated by The Holmes-Rahe Life Stress Inventory, the Clinician-administered PTSD Scale and the Impact of Event Scale. The results of this study will provide evidence whether a specific EMDR protocol for patients with BD is effective in reducing affective episodes, affective symptoms and functional, cognitive and trauma symptoms. The trial is registered at ClinicalTrials.gov, identifier: . Registered on 3 December 2015. The online version of this article (doi:10.1186/s13063-017-1910-y) contains supplementary material, which is available to authorized users.